Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral DTS-301 (paclitaxel depot) as neoadjuvant therapy in breast cancer
2005-001417-18Phase 2Terminated
- Sponsor
- Diatos S.A.
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in breast cancer, sponsored by Diatos S.A. Primary endpoints: Tumor response after intratumoral DTS-301 and Safety of intralesional DTS-301. Started Aug 2005; status: terminated.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-001417-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001417-18.